摘要
Association of tumor microenvironment and immune checkpoint (e.g., PD-L1) is important for immune escape, impacting chemotherapy and immunotherapy efficacy. We aimed to investigate biomarkers and therapeutic targets against treatment resistance in gastric cancer. Abundances of tumor-infiltrating immune cells were estimated in multiple datasets. Three patient subgroups (A, B, and C) were identified based on seven types of PD-L1- and IFN-gamma-associated immune cells. Patients yielded increased prognosis from subgroup A to C (p = 0.027). Subgroup A was characterized by high activated CD4+ memory T cell infiltration, while more resting CD4+ memory T cells were in subgroup C. Further, a risk score was developed for prognostication. Lipoma preferred partner (LPP), as the hub gene in subgroup-related regulatory network, was upregulated (p < 0.01) and was associated with high risk score (p < 0.001) and poor survival (p < 0.05). Bioinformatics analyses and experiments found that LPP expressed restrictively in fibroblasts and associated with activated CD4+ memory T cell infiltration and tumor growth. High-LPP patients yielded fewer benefits from chemotherapy or immunotherapy, compared with the low-LPP group. We finally identified 28 compounds as sensitive drugs for high-LPP patients. Our findings suggested LPP might be a biomarker for treatment response and therapeutic target in gastric cancer.
学科与关键词
- PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancerLi, Qing; Zhou, Zhi-Wei; Lu, Jia; Luo, Hao; Wang, Shu-Nan; Peng, Yu; Deng, Meng-Sheng; Song, Guan-Bin; Wang, Jian-Min; Wei, Xi; Wang, Dong*; Westover, Kenneth D.*; Xu, Cheng-Xiong*Molecular Therapy, 2022, 30(2): 621-631.被引 13
- Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric CancerXia, Yan; Lin, Xin; Cheng, Yangyang; Xu, Huimin; Zeng, Jingya; Xie, Wanlin; Wang, Mingzhu; Sun, Yihua*Frontiers in Genetics, 2022, 13: 938796.被引 1
- The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 InhibitorsChen, Li; Zhao, Ruihu; Sun, Hao; Huang, Rong; Pan, Hongming; Zuo, Yanjiao; Zhang, Lele; Xue, Yingwei; Li, Xingrui*; Song, Hongjiang*Frontiers in Pharmacology, 2022, 13: 833584.被引 4
